Your browser doesn't support javascript.
loading
Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy.
Nakamura, Yoshiaki; Yamanaka, Takeharu; Chin, Keisho; Cho, Haruhiko; Katai, Hitoshi; Terashima, Masanori; Misawa, Kazunari; Hirao, Motohiro; Yoshida, Kazuhiro; Oki, Eiji; Sasako, Mitsuru; Emi, Yasunori; Bando, Hideaki; Kawashima, Yoshiyuki; Fukunaga, Tetsu; Gotoh, Masahiro; Ishibashi, Takako; Shitara, Kohei.
Afiliação
  • Nakamura Y; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Yamanaka T; Department of Biostatistics, Yokohama City University, Yokohama, Kanagawa, Japan.
  • Chin K; Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
  • Cho H; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
  • Katai H; Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
  • Terashima M; Division of Gastric Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Misawa K; Division of Gastric Surgery, Shizuoka Cancer Center, Sunto-gun, Shizuoka, Japan.
  • Hirao M; Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
  • Yoshida K; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Osaka, Japan.
  • Oki E; Department of Surgical Oncology, Graduate School of Medicine, Gifu University, Gifu, Gifu, Japan.
  • Sasako M; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University Hospital, Fukuoka, Fukuoka, Japan.
  • Emi Y; Department of Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
  • Bando H; Department of Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, Fukuoka, Japan.
  • Kawashima Y; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Fukunaga T; Department of Gastroenterological Surgery, Saitama Cancer Center, Ina-machi, Saitama, Japan.
  • Gotoh M; Department of Gastroenterological and General Surgery, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
  • Ishibashi T; Cancer Chemotherapy Center, Osaka Medical College, Takatsuki, Osaka, Japan.
  • Shitara K; Center for Novel and Exploratory Clinical Trials, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
Ann Surg Oncol ; 26(2): 465-472, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30456678
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adjuvante / Gastrectomia / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adjuvante / Gastrectomia / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article